On July 13, 2018 the FDA announced a voluntary recall of several medicines containing valsartan, used to treat high blood pressure and heart failure. The recall is due to an impurity, N-nitrosodimethylamine (NDMA), which is classified as a probable human carcinogen.
You can learn more information about this recall here: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/UCM613532.htm
Our attorneys at Bradley, Drendel & Jeanney are currently representing several individuals who suffered injury from taking the contaminated medications containing valsartan. Our law firm is actively and aggressively investigating this matter in order to provide those affected with accurate, timely information. If you believe you or a loved one has been injured by taking a contaminated medication containing valsartan, please feel free to contact our firm.